Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022

Diabetes is the commonest cause of end-stage kidney disease in many parts of the world, and many people on dialysis programmes live with diabetes. Such people are vulnerable to complications from their diabetes, and their care may be fragmented due to the many specialists involved. This updated guidance from the Joint British Diabetes Societies aims to review and update the 2016 guidance, with particular emphasis on glycaemic monitoring in the light of recent advances in this area. In addition, the guidance covers clinical issues related to the management of diabetes in people on peritoneal dialysis, along with acute complications such as hypoglycaemia and ketoacidosis, and chronic complications such as foot and eye disease.

Automated summary

Diabetes is the leading cause of end-stage kidney disease worldwide, and its complications pose challenges for people on dialysis. The updated guidance from the Joint British Diabetes Societies focuses on glycaemic monitoring and covers clinical issues related to diabetes management in people on peritoneal dialysis, as well as acute and chronic complications.